Anna Dowe
Royal Marsden NHS Foundation Trust(GB)Cancer Genetics (United States)(US)
Publications by Year
Research Areas
BRCA gene mutations in cancer, Prostate Cancer Treatment and Research, Genetic factors in colorectal cancer, Epigenetics and DNA Methylation, Glioma Diagnosis and Treatment
Most-Cited Works
- → Two Percent of Men with Early-Onset Prostate Cancer Harbor Germline Mutations in the BRCA2 Gene(2003)365 cited
- Influence of cytokine gene polymorphisms on the development of prostate cancer.(2002)
- → Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome(2004)151 cited
- → Androgen receptor polymorphisms: Association with prostate cancer risk, relapse and overall survival(1999)151 cited
- → Linkage Analysis of Chromosome 1q Markers in 136 Prostate Cancer Families(1998)135 cited
- The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.(2000)
- → ATM polymorphisms as risk factors for prostate cancer development(2004)95 cited
- → Thalidomide as an Anti-angiogenic Agent in Relapsed Gliomas(2001)82 cited
- → Immunohistochemical expression of BRCA2 protein and allelic loss at theBRCA2 locus in prostate cancer(1998)38 cited
- → No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters(1997)38 cited